EWA
CRMD icon

EverSource Wealth Advisors’s CorMedix CRMD Stock Holding History

EverSource Wealth Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314 Buy
40
+12
+43% +$95 ﹤0.01% 4196
2026
Q1 		$190 Buy
28
+18
+180% +$133 ﹤0.01% 4206
2025
Q4 		$116 Sell
10
-1
-9% -$11 ﹤0.01% 4085
2025
Q3 		$128 Hold
11
– – ﹤0.01% 4161
2025
Q2 		$136 Buy
11
+7
+175% +$77 ﹤0.01% 4093
2025
Q1 		$25 Hold
4
– – ﹤0.01% 3955
2024
Q4 		$32 Buy
+4
New +$40 ﹤0.01% 3677

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

EverSource Wealth Advisors's CRMD Position: Q2 2026 in Review

EverSource Wealth Advisors increased its CorMedix (CRMD) stake by 43% in Q2 2026, buying an estimated $95 and bringing the position to 40 shares worth $314. The position accounts for ﹤0.01% of the portfolio, ranked #4196.

EverSource Wealth Advisors first reported a position in CRMD in Q4 2024 and has held it in 7 quarters since. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • EverSource Wealth Advisors held 40 shares of CorMedix worth $314 as of Q2 2026.
  • EverSource Wealth Advisors bought 12 CorMedix shares in Q2 2026, an estimated $95.
  • CorMedix made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4196 holding.
  • EverSource Wealth Advisors first reported a position in CorMedix in Q4 2024 and has held it in 7 quarters since.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.